August 28, 2025

FDA Requests Confirmatory Evidence on Wet AMD Therapy

Outlook Therapeutics’ drug for wet age-related macular degeneration faces an FDA approval setback.

Conexiant

August 26, 2025

FDA Begins Real-Time Reporting of Adverse Event Data

According to the FDA, the shift is one of many steps in the agency’s broader data modernization strategy to streamline all of its adverse event reporting systems and increase reporting frequency across all systems to identify safety signals faster.

Ophthalmology Management

August 21, 2025

FDA Grants RMAT to VeonGen Gene Therapy

VG801 is being developed for Stargardt disease and other ABCA4-related retinal disorders.

Retinal Physician

August 17, 2025

FDA Affirms Safety of PFAS-Based Materials in Medical Devices

PFAS used in medical devices are different from the small-molecule PFAS that have been linked to environmental and health concerns.

Contact Lens Spectrum

November 15, 2024

Eyenovia Halts Eye Drug Trial

Eyenovia's late-stage study for near-sightedness in children with an experimental drug-device combination has been discontinued after failing to slow myopia progression, leading to consideration of strategic alternatives.

Reuters

May 09, 2025

West Virginia Gains Scope of Practice Expansion

West Virginia passes a law enabling optometrists to use ophthalmic lasers, providing essential eye care services for patients, especially in rural areas, and increasing access for Medicare beneficiaries. Source: Optometric Management

Optometric Management

August 27, 2024

PCPs Play Important Role in Glaucoma Screening

“Recommendations from trusted primary providers have likely kept millions of individuals from becoming blind.”

Conexiant

February 13, 2025

FDA Approves Extended Label for Avacincaptad Pegol

The new label removes limitations on the duration of dosing.

Conexiant

January 16, 2025

LA County Fires Prompt Business Recovery Centers to Open

"Business owners can meet face-to-face with specialists to apply for disaster loans and access a wide range of resources to guide them through their recovery."

Optometric Management